Proliferative responses to human papillomavirus type 16 (HPV-16) E5 peptides were determined for short-term cell lines derived from peripheral blood mononuclear cells of 75 women. Cell lines from 16 of the 75 women proliferated in response to stimulation with pooled E5 peptides; this was most common for patients with low-grade squamous cervical intraepithelial lesions (LSIL; 6 of 15 patients, 40%) and less frequent for asymptomatic women with no cervical lesions (4 of 20, 20%), those with high-grade squamous intraepithelial lesions (HSIL; 5 of 33, 15%) and others with cervical cancer (1 of 7, 14%, P¯0±027). Amongst these patients, proliferative responses were exclusive to those that were positive for HPV-16 DNA (12 of 41, 29%; c.f. none of ...
International audienceT-cell responses ( proliferation, intracellular cytokine synthesis and IFN gam...
Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HP...
Previously, we found that human papillomavirus type 16 (HPV- 16) E5 protein is a tumor rejection ant...
Human papillomavirus type 16 (HPV-16) can cause genital warts, cervical dysplasias and carcinoma of ...
type 16 (HPV16) is a major cause of high-grade cervical intraepithelial neoplasia (CIN). Experiments...
Forty-two women attending a colposcopy clinic for evaluation of abnormal cervical cytology and 13 no...
T-cell-mediated immune responses against oncogenic human papillomaviruses (HPVs) are believed to pla...
<p>T-cell proliferation induced by E2 peptide pools were studied with PBMCs from A: women presenting...
T cell proliferative responses against human papillomavirus type 16 (HPV-16) E7 protein were studied...
Polyclonal antibodies were raised to partial and full-length synthetic peptides of human papillomavi...
A thesis submitted to the University of Luton for the degree of Doctor of PhilosophyHigh-risk mucosa...
Polyclonal antibodies were raised to partial and full-length synthetic peptides of human papillomavi...
Human papillomavirus (HPV) is believed to be the major cause of cervical cancer. To investigate whet...
T-cell responses (proliferation, intracellular cytokine synthesis and IFNγ ELISPOT) against human pa...
Human papillomavirus (HPV) infection, especially with the oncogenic genotypes, is the most important...
International audienceT-cell responses ( proliferation, intracellular cytokine synthesis and IFN gam...
Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HP...
Previously, we found that human papillomavirus type 16 (HPV- 16) E5 protein is a tumor rejection ant...
Human papillomavirus type 16 (HPV-16) can cause genital warts, cervical dysplasias and carcinoma of ...
type 16 (HPV16) is a major cause of high-grade cervical intraepithelial neoplasia (CIN). Experiments...
Forty-two women attending a colposcopy clinic for evaluation of abnormal cervical cytology and 13 no...
T-cell-mediated immune responses against oncogenic human papillomaviruses (HPVs) are believed to pla...
<p>T-cell proliferation induced by E2 peptide pools were studied with PBMCs from A: women presenting...
T cell proliferative responses against human papillomavirus type 16 (HPV-16) E7 protein were studied...
Polyclonal antibodies were raised to partial and full-length synthetic peptides of human papillomavi...
A thesis submitted to the University of Luton for the degree of Doctor of PhilosophyHigh-risk mucosa...
Polyclonal antibodies were raised to partial and full-length synthetic peptides of human papillomavi...
Human papillomavirus (HPV) is believed to be the major cause of cervical cancer. To investigate whet...
T-cell responses (proliferation, intracellular cytokine synthesis and IFNγ ELISPOT) against human pa...
Human papillomavirus (HPV) infection, especially with the oncogenic genotypes, is the most important...
International audienceT-cell responses ( proliferation, intracellular cytokine synthesis and IFN gam...
Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HP...
Previously, we found that human papillomavirus type 16 (HPV- 16) E5 protein is a tumor rejection ant...